Other
Center for Clinical Pharmacology Research Bdbeq S.A.
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 1
3(75.0%)
Phase 4
1(25.0%)
4Total
Phase 1(3)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT02132897Phase 1Completed
Fed Bioequivalence Study of CBZ Formulations
Role: lead
NCT01704898Phase 4Completed
Efavirenz Comparative Bioavailability
Role: lead
NCT01229280Phase 1Unknown
Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.
Role: lead
NCT01227811Phase 1Unknown
Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.
Role: lead
All 4 trials loaded